Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China · Delayed Price · Currency is CNY 6.35
-0.18 (-2.76%)
Nov 13, 2026, 3:00 PM CST
SHA:600222 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 272.5 | 223.59 | 180.04 | 196.67 | 311.38 | 380.55 |
Trading Asset Securities | - | 100.02 | 80.02 | 153.3 | 74.96 | 285.67 |
Cash & Short-Term Investments | 272.5 | 323.61 | 260.05 | 349.97 | 386.34 | 666.22 |
Cash Growth | -20.75% | 24.44% | -25.69% | -9.41% | -42.01% | -4.11% |
Accounts Receivable | 1,411 | 1,319 | 1,137 | 1,056 | 1,038 | 744.71 |
Other Receivables | 57.4 | 35.61 | 36.38 | 44.01 | 51.15 | 56.44 |
Receivables | 1,469 | 1,355 | 1,173 | 1,100 | 1,089 | 801.15 |
Inventory | 439.43 | 353.83 | 367.67 | 455.5 | 450.49 | 381.85 |
Other Current Assets | 113.82 | 108.96 | 105.35 | 87.88 | 105.03 | 94.49 |
Total Current Assets | 2,295 | 2,141 | 1,906 | 1,993 | 2,031 | 1,944 |
Property, Plant & Equipment | 455.15 | 487.21 | 501.82 | 529.65 | 551.13 | 539.58 |
Long-Term Investments | 475.89 | 472.61 | 526.67 | 520.38 | 490.93 | 825.63 |
Goodwill | 286.49 | 286.49 | 286.49 | 286.49 | 286.49 | 286.49 |
Other Intangible Assets | 46.72 | 49.9 | 51.17 | 52.5 | 48.11 | 53.1 |
Long-Term Deferred Tax Assets | 94.19 | 97.97 | 113.2 | 94.24 | 95.38 | 52.4 |
Long-Term Deferred Charges | 56.21 | 56.04 | 52.8 | 49.81 | 54.23 | 35.81 |
Other Long-Term Assets | 50.26 | 50.1 | 51.55 | 50.71 | 49.08 | 47.05 |
Total Assets | 3,759 | 3,642 | 3,490 | 3,577 | 3,607 | 3,784 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 430.52 | 342.59 | 294.89 | 470.29 | 548.89 | 355.65 |
Accrued Expenses | 13.39 | 37.99 | 28.26 | 24.27 | 32.22 | 22.45 |
Short-Term Debt | 592.71 | 507.49 | 663.42 | 381.84 | 404.87 | 973.58 |
Current Portion of Long-Term Debt | 233.16 | 165.1 | 270.07 | 89.76 | 4.22 | 158.74 |
Current Portion of Leases | - | 12.01 | 46.29 | 35.35 | 26.89 | - |
Current Income Taxes Payable | 7.72 | 1.25 | 1.28 | 2.53 | 21.86 | 3.7 |
Current Unearned Revenue | 5.19 | 2.63 | 6.54 | 11.62 | 88.26 | 49.47 |
Other Current Liabilities | 562.79 | 804.56 | 483.76 | 634.5 | 598.82 | 86.09 |
Total Current Liabilities | 1,845 | 1,874 | 1,795 | 1,650 | 1,726 | 1,650 |
Long-Term Debt | 180.22 | 61.76 | 3.02 | 183.8 | 192.8 | 20.37 |
Long-Term Leases | 19.45 | 24.22 | 42.04 | 89.29 | 37.14 | 72.06 |
Long-Term Unearned Revenue | 3.12 | 2.44 | 2.78 | 3.26 | 1.71 | - |
Long-Term Deferred Tax Liabilities | 18.04 | 16.94 | 21.16 | 25.36 | 33.26 | 132.42 |
Other Long-Term Liabilities | 12.78 | - | - | 1.62 | 1.62 | 131.62 |
Total Liabilities | 2,079 | 1,979 | 1,864 | 1,953 | 1,993 | 2,006 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 559.36 | 573.89 | 573.89 | 573.89 | 573.89 | 573.89 |
Additional Paid-In Capital | 609.95 | 675.15 | 675.17 | 675.17 | 675.17 | 588.14 |
Retained Earnings | 419.68 | 403.44 | 316.01 | 281.01 | 237.46 | 232.15 |
Treasury Stock | -30.07 | -109.8 | -101.01 | -79.72 | -37.66 | -48.7 |
Comprehensive Income & Other | 60.69 | 61.67 | 110.67 | 128.15 | 121.56 | 315.04 |
Total Common Equity | 1,620 | 1,604 | 1,575 | 1,578 | 1,570 | 1,661 |
Minority Interest | 60.78 | 58.19 | 51.51 | 44.89 | 43.62 | 117.13 |
Shareholders' Equity | 1,680 | 1,663 | 1,626 | 1,623 | 1,614 | 1,778 |
Total Liabilities & Equity | 3,759 | 3,642 | 3,490 | 3,577 | 3,607 | 3,784 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,026 | 770.59 | 1,025 | 780.03 | 665.92 | 1,225 |
Net Cash (Debt) | -753.03 | -446.98 | -764.79 | -430.07 | -279.58 | -558.53 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.36 | -0.81 | -1.37 | -0.76 | -0.50 | -1.00 |
Filing Date Shares Outstanding | 552.82 | 552.92 | 554.67 | 559.36 | 566.69 | 563.04 |
Total Common Shares Outstanding | 552.82 | 552.92 | 554.67 | 559.36 | 566.69 | 563.04 |
Working Capital | 449.1 | 267.58 | 111.55 | 342.93 | 305.21 | 294.03 |
Book Value Per Share | 2.93 | 2.90 | 2.84 | 2.82 | 2.77 | 2.95 |
Tangible Book Value | 1,286 | 1,268 | 1,237 | 1,239 | 1,236 | 1,321 |
Tangible Book Value Per Share | 2.33 | 2.29 | 2.23 | 2.22 | 2.18 | 2.35 |
Buildings | - | 558.12 | 556.93 | 543.26 | 534.9 | 520.76 |
Machinery | - | 374.14 | 361.45 | 341.92 | 316.19 | 281.14 |
Construction In Progress | - | 26.59 | 29.2 | 28.9 | 31.1 | 33.02 |